Exane BNP Paribas upgraded Zscaler from Neutral to Outperform and set a new price target of $260.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/13/2025 | $385.00 | Equal Weight → Overweight | Wells Fargo |
| 5/30/2025 | $260.00 | Overweight → Neutral | Piper Sandler |
| 4/28/2025 | $260.00 | Neutral → Outperform | Exane BNP Paribas |
| 4/23/2025 | $215.00 | Neutral | Roth Capital |
| 4/3/2025 | $250.00 | Neutral → Overweight | Cantor Fitzgerald |
| 4/1/2025 | $255.00 | Overweight | Stephens |
| 3/18/2025 | Equal-Weight | Morgan Stanley | |
| 3/7/2025 | $215.00 → $240.00 | Neutral → Buy | BofA Securities |